<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>J Varley-Campbell | Tristan Snowsill</title>
    <link>/author/j-varley-campbell/</link>
      <atom:link href="/author/j-varley-campbell/index.xml" rel="self" type="application/rss+xml" />
    <description>J Varley-Campbell</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2020 Tristan Snowsill</copyright><lastBuildDate>Fri, 01 Mar 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu050d7ab96a8b87ebb29a3f4b58eca100_52805_512x512_fill_lanczos_center_2.png</url>
      <title>J Varley-Campbell</title>
      <link>/author/j-varley-campbell/</link>
    </image>
    
    <item>
      <title>Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation</title>
      <link>/publication/varley-campbell-2019-three-biomarker-tests-to-help-diagnose-preterm-labour/</link>
      <pubDate>Fri, 01 Mar 2019 00:00:00 +0000</pubDate>
      <guid>/publication/varley-campbell-2019-three-biomarker-tests-to-help-diagnose-preterm-labour/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Do we know enough about the effect of low-dose computed tomography screening for lung cancer on survival to act? A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.</title>
      <link>/publication/yang-2019-do-we-know-enough-about-the-effect-of-low-dose-computed-tomography/</link>
      <pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate>
      <guid>/publication/yang-2019-do-we-know-enough-about-the-effect-of-low-dose-computed-tomography/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Low-dose computed tomography for lung cancer screening in high-risk populations: A systematic review and economic evaluation</title>
      <link>/publication/snowsill-2018-low-dose-computed-tomograph-for-lung-cancer-screening/</link>
      <pubDate>Thu, 01 Nov 2018 00:00:00 +0000</pubDate>
      <guid>/publication/snowsill-2018-low-dose-computed-tomograph-for-lung-cancer-screening/</guid>
      <description></description>
    </item>
    
    <item>
      <title>BIOMARKER TESTS TO HELP DIAGNOSE PRETERM LABOUR IN SYMPTOMATIC WOMEN WITH INTACT MEMBRANES: A SYSTEMATIC REVIEW</title>
      <link>/publication/barnish-2018-biomarker-tests-to-help-diagnose-preterm-labour/</link>
      <pubDate>Sat, 01 Sep 2018 00:00:00 +0000</pubDate>
      <guid>/publication/barnish-2018-biomarker-tests-to-help-diagnose-preterm-labour/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England</title>
      <link>/publication/tikhonova-2018-economic-analysis-of-first-line-treatment-with-cetuximab/</link>
      <pubDate>Sun, 01 Jul 2018 00:00:00 +0000</pubDate>
      <guid>/publication/tikhonova-2018-economic-analysis-of-first-line-treatment-with-cetuximab/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: A systematic review and economic evaluation</title>
      <link>/publication/huxley-2017-the-clinical-effectiveness-and-cost-effectiveness-of-cetuximab/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>/publication/huxley-2017-the-clinical-effectiveness-and-cost-effectiveness-of-cetuximab/</guid>
      <description></description>
    </item>
    
    <item>
      <title>AZACITIDINE FOR TREATING ACUTE MYELOID LEUKAEMIA: A NICE SINGLE TECHNOLOGY APPRAISAL</title>
      <link>/publication/tikhonova-2016-azacitidine-for-treating-acute-myeloid-leukaemia/</link>
      <pubDate>Tue, 01 Nov 2016 00:00:00 +0000</pubDate>
      <guid>/publication/tikhonova-2016-azacitidine-for-treating-acute-myeloid-leukaemia/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model</title>
      <link>/publication/jones-hughes-2016-immunosuppressive-therapy-for-kidney-transplantation/</link>
      <pubDate>Mon, 01 Aug 2016 00:00:00 +0000</pubDate>
      <guid>/publication/jones-hughes-2016-immunosuppressive-therapy-for-kidney-transplantation/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immunosuppressive therapy for kidney transplantation in children and adolescents: Systematic review and economic evaluation</title>
      <link>/publication/haasova-2016-immunosuppressive-therapy-for-kidney-transplantation-in-children/</link>
      <pubDate>Mon, 01 Aug 2016 00:00:00 +0000</pubDate>
      <guid>/publication/haasova-2016-immunosuppressive-therapy-for-kidney-transplantation-in-children/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COST EFFECTIVENESS OF CETUXIMAB AND PANITUMUMAB FOR FIRST-LINE RAS WT METASTATIC COLORECAL CANCER</title>
      <link>/publication/tikhonova-2016-cost-effectiveness-of-cetuximab-and-panitumumab/</link>
      <pubDate>Sun, 01 May 2016 00:00:00 +0000</pubDate>
      <guid>/publication/tikhonova-2016-cost-effectiveness-of-cetuximab-and-panitumumab/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Immunosuppressive therapy for renal transplantation in adults: a systematic review and network meta-analyses.</title>
      <link>/publication/haasova-2016-immunosuppressive-therapy-for-renal-transplantation-in-adults/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>/publication/haasova-2016-immunosuppressive-therapy-for-renal-transplantation-in-adults/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
